首页> 外文期刊>The Egyptian Journal of Hospital Medicine >Hepatic Expression of the Proliferative Marker Ki-67 and cell cycle p53 Protein in chronic hepatitis C (A histopathological and immunohistochemical study)
【24h】

Hepatic Expression of the Proliferative Marker Ki-67 and cell cycle p53 Protein in chronic hepatitis C (A histopathological and immunohistochemical study)

机译:慢性丙型肝炎中增殖标志物Ki-67和细胞周期p53蛋白的肝表达(组织病理学和免疫组化研究)

获取原文
           

摘要

Aim and background: To evaluate hepatic expression of the nuclear proliferative marker Ki-67 and the cell cycle marker p53 oncoprotein in chronic hepatitis C in relation to the advanced stages of liver fibrosis in HCV positive Egyptian patients . Material & Methods: Paraffin-embedded liver biopsy specimens were studied from 21 untreated patients with chronic HCV infection. All patients were HCV antibody positive, as determined by a commercially available enzyme-linked immunosorbent assay kit. Patients having other etiologies for chronic liver disease including HBV infection were not included in this study. Liver biopsies were obtained percutaneous. All biopsies were fixed in formalin, embedded in paraffin, and sectioned by microtome with a thickness of 5 μm. Routine specimen processing involved staining slides with hematoxylin and eosin (5 levels), Masson's trichrome stain (5 levels), for a total of 10 levels per specimen All levels were screened. All specimens were examined by two pathologists, and classified by consensus for all abnormal histological findings. The histological activity index (or histological grade) was determined using Ishak grading scheme22 expressed as a semiquantitative score for portal inflammation (0-4), lobular activity sporadic lytic foci (0-4) and parenchymal confluent necrosis (0-6), and piecemeal necrosis(0-4). The extent of fibrosis (or histological stage) was determined using Ishak score (0-6). Steatosis was scored according to Keliner et al 2005 , from grade 0 to 3; where S0 = no steatosis or less than 5% (low or medium power evaluation) of parenchymal involvement by fatty changes, S1 (mild) = 5%-33%, S2 (moderate) = >33%-66% and S3 (severe) > 66% of the hepatocytes are involved by fatty changes. Expression of p53 and Ki67 were determined by immunohistochemistry, using avidin-biotin-peroxidase. Results: Liver histology: The studied group (n = 21) involved 16 males and 5 females (male to female ratio 3.3:1). The histopathological findings of HCV infection, including portal lymphoid infiltration, periportal piecemeal necrosis, lymphocyte infiltration of the lobules, hepatocellular necrosis, steatosis and fibrosis, were studies. The age ranged from 31 to 59 years old with mean of 44.86 ± 8.74, males 76.2%, females 23.8% .P53 expression was positive in 52.4% and negative in 47.6%. cytoplasmic localization dominated over nuclear expression. Ki 67 was negative in 81% of cases and positive in19% of cases, all cases in stage 6 were positive for p53 while there were no difference in the other stages of fibrosis, and this relation was statistically significant. There was no relation between the grade of necro-inflammation and the expression of p53,
机译:目的和背景:评估与丙型肝炎病毒阳性埃及患者肝纤维化晚期有关的慢性丙型肝炎中肝增殖核标志物Ki-67和细胞周期标志物p53癌蛋白的肝表达。材料与方法:从21名未经治疗的慢性HCV感染患者中研究石蜡包埋的肝活检标本。通过市售酶联免疫吸附测定试剂盒确定,所有患者均为HCV抗体阳性。具有其他慢性肝病病因(包括HBV感染)的患者不包括在本研究中。经皮肝活检。所有活组织检查均固定在福尔马林中,包埋在石蜡中,并用切片机切片,厚度为5μm。常规标本处理包括用苏木精和曙红(5级),Masson三色染料(5级)对载玻片染色,每个标本共10级。筛选所有级。所有标本均由两名病理学家检查,并对所有异常组织学发现按共识分类。使用Ishak分级方案22确定组织学活动指数(或组织学等级),该分级表示为门脉炎症(0-4),小叶活动性散发性病灶(0-4)和实质融合性坏死(0-6)的半定量评分,以及零碎坏死(0-4)。使用Ishak评分(0-6)确定纤维化程度(或组织学分期)。脂肪变性是根据Keliner et al 2005(从0到3级)评分的;其中S0 =无脂肪变性或少于5%(通过脂肪变化引起的实质参与)(S1(轻度)= 5%-33%,S2(中度)=> 33%-66%和S3(严重) )> 66%的肝细胞参与脂肪变化。使用抗生物素蛋白-生物素-过氧化物酶通过免疫组织化学测定p53和Ki67的表达。结果:肝组织学:研究组(n = 21)包括16位男性和5位女性(男女比例为3.3:1)。研究了HCV感染的组织病理学发现,包括门静脉淋巴样浸润,门静脉小段坏死,小叶淋巴细胞浸润,肝细胞坏死,脂肪变性和纤维化。年龄为31-59岁,平均44.86±8.74岁,男性76.2%,女性23.8%。P53表达阳性的占52.4%,阴性的占47.6%。细胞质定位在核表达中占主导地位。 Ki 67在81%的病例中为阴性,在19%的病例中为阳性,在第6阶段的所有病例中p53均为阳性,而在其他纤维化阶段则无差异,这一关系具有统计学意义。坏死性炎症的程度与p53的表达无关,

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号